Stocks and InvestingStocks and Investing
Fri, July 9, 2021
Thu, July 8, 2021
Wed, July 7, 2021
Tue, July 6, 2021
Mon, July 5, 2021
Fri, July 2, 2021
Thu, July 1, 2021
Wed, June 30, 2021

Jonathan Wolleben Maintained (ALT) at Buy with Decreased Target to $31 on, Jun 30th, 2021


Published on 2024-10-27 17:05:14 - WOPRAI, Jonathan Wolleben
  Print publication without navigation


Jonathan Wolleben of JMP Securities, Maintained "Altimmune, Inc." (ALT) at Buy with Decreased Target from $53 to $31 on, Jun 30th, 2021.

Jonathan, nor any peers, have made any analyst calls on ALT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30